Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s
|
Nov 21, 2024 |
Fever prevention and stroke, environmental toxins and Parkinson’s, cholesterol overload and ALS progression
|
Nov 07, 2024 |
Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder
|
Oct 17, 2024 |
Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke
|
Oct 03, 2024 |
Brain circuit underlying placebo pain relief, common Parkinson’s gene variants, blood biomarker testing for Alzheimer’s
|
Sep 19, 2024 |
Alzheimer’s diagnosis criteria, AI and Parkinson’s severity, neurotoxicity of racism
|
Sep 05, 2024 |
Weight loss drugs and optic neuropathy, normothermic regional perfusion, APPs in neurology practice
|
Aug 15, 2024 |
Body composition and neurologic disease, Tenecteplase and stroke related-disability, comorbid stroke and cancer
|
Jul 31, 2024 |
Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab
|
Jul 18, 2024 |
Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology
|
Jul 04, 2024 |
When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs.
|
Jun 20, 2024 |
Code for ICH, new findings on Havana syndrome, distal symmetric polyneuropathy underdiagnosed in low income primary care clinics
|
Jun 06, 2024 |
Surgical removal of hematoma in ICH, disparities in neurodiagnosis for epilepsy, inequities among female neurology researchers
|
May 16, 2024 |
Generative AI for personal statements, Match Day and neurology, AHS statement on CGRP-targeting therapies
|
May 02, 2024 |
ME/CFS and long COVID; negative outcomes for ALS drug; donanemab
|
Apr 18, 2024 |
BTK inhibitors for MS, lecanemab, neurologic adverse effects and COVID vaccine
|
Apr 04, 2024 |
SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens
|
Mar 21, 2024 |
AI and 911 stroke detection, iatrogenic Alzheimer’s and human growth hormone, seizure dogs and refractory epilepsy
|
Mar 07, 2024 |
Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders
|
Feb 12, 2024 |
Cerebral amyloid angiopathy and nontraumatic subdural hemorrhage, AI for neurology boards, weight loss drugs and neurologic conditions
|
Jan 25, 2024 |
Rising incidence of Creutzfeldt-Jakob disease, therapy for prodromal migraine, neurotrauma of blast injury
|
Jan 16, 2024 |
DBS and cognition in severe TBI, in utero exposure to antiseizure drugs, best advances of 2023
|
Jan 02, 2024 |
Parkinson’s and suicide risk; biomarkers and underrepresentation in Alzheimer’s trials, immune system changes in ALS and Parkinson’s.
|
Dec 21, 2023 |
Serotonin and long COVID, Afib detected 3 years after stroke, Medicare on PET amyloid scans
|
Dec 07, 2023 |
A promising drug for refractory epilepsy; adverse childhood events and headache disorders; pathological engulfment by microglia in dementia.
|
Nov 16, 2023 |
Blood transfusions and spontaneous intracerebral hemorrhages, long distance travel to neurologists, biomarkers for Parkinson’s disease
|
Nov 02, 2023 |
Blood pressure and endovascular therapy, cutbacks in neurology CME, blood test for Alzheimer’s
|
Oct 19, 2023 |
Football and Parkinson’s, deep brain stimulation for stroke recovery, neuroprostheses for anarthric patients
|
Oct 05, 2023 |
Medicare coverage of carotid stenting, disparities in vulnerable neuro-oncology patients, optical EMG for neuromuscular disorders.
|
Sep 21, 2023 |
Endovascular treatment and intracranial tumors; guideline on IVIG use for neuromuscular disorders, pros and cons of donanemab.
|
Sep 07, 2023 |
Oral health and cognitive decline; managing first-ever sleep seizures; growth of concierge neurology.
|
Aug 17, 2023 |
Gene variants and MS severity, AI and EEG reads, neuroprotective agent for ischemic stroke
|
Aug 03, 2023 |
Antigen tolerance in mouse MS model, epileptiform activity and ICU outcomes, agent slows gliomas.
|
Jul 20, 2023 |
Gout and risk of neurodegenereative diseases, Tenecteplase compared with warfarin, cognitive decline after heart attack
|
Jul 06, 2023 |
Antipsychotic for dementia-related agitation, contaminated water at Camp Lejeune associated with elevated risk for Parkinson’s, gene variant confers resilience against autosomal dominant Alzheimer’s.
|
Jun 15, 2023 |
OnabotulinumtoxinA for pregnant women with migraine, adderrall shortage, AI for epilepsy
|
Jun 01, 2023 |
Assay detects Parkinson’s before symptom onset; life stressors in pregnant women with epilepsy; role of inflammation in NORSE
|
May 18, 2023 |
Anticoagulants for patients with dementia and Afib, tau levels in women taking hormone replace therapy, neurohumanities programs for neurology residents.
|
May 04, 2023 |
Fertility treatments for women with MS, stroke systems of care, ravalizumab for NMOSD
|
Apr 20, 2023 |
Intranasal CGRP for migraine, ultrasound ablation for Parkinson’s disease, novel therapeutic pathway for Duchenne muscular atrophy.
|
Apr 06, 2023 |
Antipsychotics and dementia risk; biomarkers for lecanemab eligibility; trial of difelikefalin for neurogenic itch in notaliga paresthetica.
|
Mar 16, 2023 |
Pregnancy-associated stroke outcomes; a robotic device for shoulder movement in ALS; non-invasive neurostimulation for refractory seizures.
|
Mar 02, 2023 |
Acute infections and increased risk for dementia, alternatives to CPAP for sleep apnea; the legacy of Dr. Ralph Sacco.
|
Feb 16, 2023 |
IV thrombolysis for large vessel occlusion; impact of mindfulness, exercise on cognition;new brain layer in subarachnoid space.
|
Feb 02, 2023 |
Best advances of 2022, misdiagnosed autoimmune encephalitis, inflation his neurology private practice
|
Jan 19, 2023 |
Spinal cord stimulation for chronic pain, disparities in brain age by race/ethnicity, careers in teleneurology
|
Jan 04, 2023 |
Rituximab for MS, food security and cognition, in utero treatment for Pompe disease
|
Dec 15, 2022 |
Modifiable risk factors for monogenic stroke, health care systems prepare for wave of new Alzheimer’s therapies, criteria for selecting neurology residents
|
Dec 01, 2022 |
Revascular therapies for stroke patients with COVID, dementia and suicide risk, hyperbaric oxygen therapy for concussion in children.
|
Nov 17, 2022 |
Allergies and dementia risk, folic acid and risk of cancer in children of women with epilepsy, climate change and neurologic disorders.
|
Nov 03, 2022 |
Vamorolone for DMD, aquaporin protein and amyloid clearance, monkey pox-associated neurologic events.
|
Oct 20, 2022 |
Chronic kidney disease and risk for intracerebral hemorrhage, gonadotropic replacement and cogntion in Down syndrome, how to distinguish polio from other viruses
|
Oct 06, 2022 |
Decompression and Chiari malformation, atrial cardiopathy and dementia risk, 3D printing the brain.
|
Sep 15, 2022 |
Processed foods and dementia risk, therapies for vertigo, impostor syndrome
|
Sep 01, 2022 |
Spinal cord stimulation for diabetic neuropathy, Roe v. Wade reversal, diversifying the neurology pipeline.
|
Aug 18, 2022 |
Functional neurologic disorder, newborn screening for SMA, when to leave job
|
Aug 04, 2022 |
Functional neurologic disorder, newborn screening for SMA, when to leave job
|
Aug 04, 2022 |
Brain aneurysm rupture, COVID-19 exposure in utero, socioeconomics and brain development.
|
Jul 21, 2022 |
Monkeypox, soticelstat for epilepsy, gabapentin for stroke recovery.
|
Jul 07, 2022 |
Fenfluramine for LGS, social isolation and dementia risk, neurology’s status in NRMP match.
|
Jun 16, 2022 |
Teleneurology in rural America, trauma-informed neurology,advances in neurogenetics
|
Jun 02, 2022 |
Portable MRI for stroke, SSRIs and seizure risk in neonates, neurology training in Ukraine.
|
May 19, 2022 |
Blood pressure trajectories, Parkinson’s risk factors, neurology residents, Potamkin Award
|
May 05, 2022 |
Gabapentin as a controlled substance embolic stroke of undetermined source, how to become a clinician educator
|
Apr 21, 2022 |
Neurologists in Ukraine, neurology costs discussions, statins and parkinsonism
|
Apr 07, 2022 |
New Parkinson’s therapies, antiseizure drugs in pregnancy, endovascular therapy for large core stroke
|
Mar 17, 2022 |
Parkinson’s in women, gene therapy for LGMD, advance for severe SCI
|
Mar 03, 2022 |
Gender Bias in Medicare Criteria for Sleep Apnea and More
|
Feb 17, 2022 |
February 3-Issue Introduction
|
Feb 03, 2022 |
January 20- Issue Introduction
|
Jan 21, 2022 |
January 6- Issue Introduction
|
Jan 06, 2022 |
December 16- Issue Introduction
|
Dec 17, 2021 |
December 2- Issue Introduction
|
Dec 03, 2021 |
November 18 - Issue Introduction
|
Nov 19, 2021 |
November 4- Issue Introduction
|
Nov 08, 2021 |
October 21- Issue Introduction
|
Oct 21, 2021 |
October 7- Issue Introduction
|
Oct 07, 2021 |
September 16- Issue Introduction
|
Sep 16, 2021 |
September 2- Issue Introduction
|
Sep 04, 2021 |
August 19- Issue Introduction
|
Aug 24, 2021 |
August 5- Issue Introduction
|
Aug 05, 2021 |
July 22- Issue Introduction
|
Jul 22, 2021 |
July 8- Issue Introduction
|
Jul 09, 2021 |
June 17- Issue Introduction
|
Jun 17, 2021 |
June 3- Issue Introduction
|
Jun 03, 2021 |
May 20- Issue Introduction
|
May 19, 2021 |
May 6- Issue Introduction
|
May 06, 2021 |
April 15- Issue Introduction
|
Apr 15, 2021 |
April 1- Issue Introduction
|
Mar 31, 2021 |
March 4- Issue Introduction
|
Mar 04, 2021 |
February 18- Issue Introduction
|
Feb 17, 2021 |
February 21- Issue Introduction
|
Feb 03, 2021 |
January 21- Issue Introduction
|
Jan 21, 2021 |
January 7- Issue Introduction
|
Jan 05, 2021 |
December 17 - Issue Introduction
|
Dec 15, 2020 |
December 3- Issue Introduction
|
Dec 02, 2020 |
November 19- Issue Introduction
|
Nov 18, 2020 |
November 5- Issue Introduction
|
Nov 04, 2020 |
October 22- Issue Introduction
|
Oct 20, 2020 |
October 8- Issue Introduction
|
Oct 08, 2020 |